APLEXIA PHARMA LIMITED
Significant control: Dhananjay Kumar Mishra (25–50%), Nita Mishra (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Aplexia Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Aplexia Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
APLEXIA PHARMA LIMITED is an active private limited company (company number 14663026) incorporated on 14 February 2023, registered in Barnet. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest dormant accounts cover the period ending 28 February 2025, showing net assets of £2 and cash of £2. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 86 comparable companies in Greater London (median £100, upper quartile £35k).
Ownership and control
- Mr Dhananjay Kumar Mishra
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Mrs Nita Mishra
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 14 February 20233 yrs ago
- Next accounts due
- 28 November 2026in 30 days
- Confirmation statement due
- 28 February 2027in 122 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 86102
- Medical nursing home activities
- Accounts type
- Dormant
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | £2 | £2 | — | — | — | — | — |
| 28 February 2024 | £2 | £2 | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £2 at 28 February 2025
- Incorporated two to five years agoIncorporated 14 February 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 122 days
- Next accounts duein 30 days
- Accounts period endNet assets £2 · dormant accounts
- Accounts period endNet assets £2 · dormant accounts
- Incorporated
Similar companies in Greater London
- JASNEY LIMITEDDartford · inc. Mar 2023
- COMPOUNDING LAB LTDHornchurch · inc. Jan 2023
- LIVEALTH BIOPHARMA (UK) PVT. LTDWembley · inc. Apr 2023
- VETRON HEALTH PRODUCTS LTDFeltham · inc. Nov 2022
- OZNER MEDIKAL SANAYI VE TICARET (LONDON) LTDCroydon · inc. Nov 2022
- RENOVA LIFESCIENCES LIMITEDWoodford Green · inc. Jun 2023
All companies incorporated on 14 February 2023 · in Feb 2023.
Reminders for APLEXIA PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.